SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.
Human Molecular Genetics
Ramirez, Alfredo A; van der Flier, Wiesje M WM; Herold, Christine C; Ramonet, David D; Heilmann, Stefanie S; Lewczuk, Piotr P; Popp, Julius J; Lacour, André A; Drichel, Dmitriy D; Louwersheimer, Eva E; Kummer, Markus P MP; Cruchaga, Carlos C; Hoffmann, Per P; Teunissen, Charlotte C; Holstege, Henne H; Kornhuber, Johannes J; Peters, Oliver O; Naj, Adam C AC; Chouraki, Vincent V; Bellenguez, Céline C; Gerrish, Amy A; , ; , ; Heun, Reiner R; Frölich, Lutz L; Hüll, Michael M; Buscemi, Lara L; Herms, Stefan S; Kölsch, Heike H; Scheltens, Philip P; Breteler, Monique M MM; Rüther, Eckart E; Wiltfang, Jens J; Goate, Alison A; Jessen, Frank F; Maier, Wolfgang W; Heneka, Michael T MT; Becker, Tim T; Nöthen, Markus M MM